Exploring the Association of Bacterial Coinfections with Clinical Characteristics of Patients with Nontuberculous Mycobacterial Pulmonary Disease

被引:0
|
作者
Moon, Seong Mi [1 ,2 ]
Cho, Hyunkyu [1 ]
Shin, Beomsu [3 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Pulm & Crit Care Med,Dept Med, Chang Won, South Korea
[2] Chungbuk Natl Univ, Div Pulm & Crit Care Med, Coll Med, Dept Internal Med,Chungbuk Natl Univ Hosp, Cheongju, South Korea
[3] Gachon Univ, Gil Med Ctr, Dept Allergy Pulm & Crit Care Med, Coll Med, 21 Namdong Daero 774Beon Gil, Incheon 21565, South Korea
基金
新加坡国家研究基金会;
关键词
Nontuberculous Mycobacteria; Bacterial Coinfection; Bronchiectasis; Bronchiectasis Severity; Pseudomonas Aeruginosa; BRONCHIECTASIS; IMPACT;
D O I
10.4046/trd.2024.0003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Clinical data for bacterial coinfection of the lower respiratory tract in patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) are scarce. This study aims to assess the prevalence of bacterial coinfection and clinical features in NTM-PD patients. Methods: This retrospective study screened 248 patients with NTM-PD who underwent bronchoscopy between July 2020 and July 2022, from whom newly diagnosed NTM-PD patients were analyzed. Bacterial culture using bronchial washing fluid was performed at the time of NTM-PD diagnosis. Results: In the 180 patients (median age 65 years; 68% female), Mycobacterium avium complex (86%) was the most frequent NTM isolated. Bacterial coinfections were detected in 80 (44%) patients. Among them, the most common bacterium was Klebsiella pneumoniae (n=25/80, 31.3%), followed by Pseudomonas aeruginosa (n=20/80, 25%) and Staphylococcus aureus (n=20/80, 25%). Compared with NTM-PD patients without bacterial coinfections, patients with bacterial coinfections showed more frequent extensive lung involvement (33% vs. 1%, p<0.001). Additionally, compared with NTM-PD patients without P. aeruginosa infection, those with P. aeruginosa infection were older (74 years vs. 64 years, p=0.001), had more frequent respiratory symptoms (cough/excessive mucus production 70% vs. 38%, p=0.008; dyspnea 30% vs. 13%, p=0.047), and had extensive lung involvement (60% vs. 9%, p<0.001). Conclusion: Less than half of patients with newly diagnosed NTM-PD had bacterial coinfections, linked to extensive lung involvement. Specifically, P. aeruginosa coinfection was significantly associated with older age, more frequent respiratory symptoms, and extensive lung involvement.
引用
收藏
页码:505 / 513
页数:9
相关论文
共 50 条
  • [21] Similar characteristics of nontuberculous mycobacterial pulmonary disease in men and women
    Holt, Michael R.
    Kasperbauer, Shannon H.
    Koelsch, Tilman L.
    Daley, Charles L.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (01)
  • [22] Phenotypic, immunologic, and clinical characteristics of patients with nontuberculous mycobacterial lung disease in Korea
    Lee, Ae-Ra
    Lee, Jinwoo
    Choi, Sun-Mi
    Seong, Moon-Woo
    Kim, Sung A.
    Kim, Myoungsil
    Chae, Kyung Ok
    Lee, Ji Sun
    Yim, Jae-Joon
    BMC INFECTIOUS DISEASES, 2013, 13
  • [23] Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease
    Park, Sojung
    Jo, Kyung-Wook
    Lee, Sang-Do
    Kim, Woo Sung
    Shim, Tae Sun
    RESPIRATORY MEDICINE, 2017, 133 : 36 - 41
  • [24] Phenotypic, immunologic, and clinical characteristics of patients with nontuberculous mycobacterial lung disease in Korea
    Ae-Ra Lee
    Jinwoo Lee
    Sun-Mi Choi
    Moon-Woo Seong
    Sung A Kim
    Myoungsil Kim
    Kyung Ok Chae
    Ji Sun Lee
    Jae-Joon Yim
    BMC Infectious Diseases, 13
  • [25] Management of nontuberculous mycobacterial pulmonary disease
    Adelman, Mark H.
    Addrizzo-Harris, Doreen J.
    CURRENT OPINION IN PULMONARY MEDICINE, 2018, 24 (03) : 212 - 219
  • [26] Pharmacotherapy for nontuberculous mycobacterial pulmonary disease
    Velagapudi, Manasa
    Sanley, Michael J.
    Ased, Sumaya
    Destache, Chris
    Malesker, Mark A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (06) : 437 - 445
  • [27] Profiling mycobacterial communities in pulmonary nontuberculous mycobacterial disease
    Cowman, Steven A.
    James, Phillip
    Wilson, Robert
    Cookson, William O. C.
    Moffatt, Miriam F.
    Loebinger, Michael R.
    PLOS ONE, 2018, 13 (12):
  • [28] The Association between Behavioral Risk Factors and Nontuberculous Mycobacterial Pulmonary Disease
    Park, Youngmok
    Kwak, Se Hyun
    Yong, Seung Hyun
    Lee, Su Hwan
    Leem, Ah Young
    Kim, Song Yee
    Lee, Sang Hoon
    Chung, Kyungsoo
    Kim, Eun Young
    Jung, Ji Ye
    Park, Moo Suk
    Kim, Young Sam
    Chang, Joon
    Kang, Young Ae
    YONSEI MEDICAL JOURNAL, 2021, 62 (08) : 702 - 707
  • [29] Outcomes of Robotic Surgery in Patients with Pulmonary Nontuberculous Mycobacterial Disease
    Mcguire, E. L.
    Saini, S.
    Luoma, K.
    Zervos, M.
    Cerfolio, R. J.
    Addrizzo-Harris, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [30] Clinical characteristics and treatment outcomes of patients with nontuberculous mycobacterial pulmonary disease in South Gyeongsang Province: A single centre experience
    Moon, Seong Mi
    Cho, Hyun Kyu
    Jung, Jae Wan
    Shin, Beomsu
    Ock, Hyesung
    Rhyou, Hyo-In
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64